iShares Treasury Floating Rate Bond ETF (ARCA: TFLO)

Latest news for iShares Treasury Floating Rate Bond ETF (ARCA:TFLO)

iShares Treasury Floating Rate Bond ETF

The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The underlying index is a market capitalization-weighted index that measures the performance of floating rate public obligations of the U.S. Treasury.

Blackrock Cash Funds: Treasury, Sl Agency Shares

ETF Winners And Losers: Medium-Cap Fund Flows - iShares’ TFLO Adds Over $3 Billion, TLH Loses $624.5 Million

News

ETFs

AVGO

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TFLO

VGLT

We performed a screening of medium-cap ETFs - defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest change in net assets on the week, according to data from etfdb.com. Only non-leveraged funds were considered.
Winners
iShares Treasury Floating Rate Bond ETF (NYSEARCA: TFLO)


ETF Winners And Losers: Medium-Cap Fund Flows - iShares&#39; TFLO Adds Over $3 Billion, TLH Loses $624.5 Million

Long Ideas

Sector ETFs

Markets

Trading Ideas

USFR

Ray Dalio, billionaire investor and founder of Bridgewater Associates, has quoted legendary economist John Maynard Keynes to express what he feels about cash as an asset in the current econ

Ray Dalio No Longer Believes Cash Is Trash: &#39;When Facts Change, I Change My Mind&#39;

Contracts

NVEE

NV5 Announces $14M In Municipal Infrastructure Contracts In Southern California

WIIM

TRNR

Interactive Strength shares are trading higher after the company announced its board approved a Bitcoin purchase plan worth up to $5 million.

Digital shopping solution allows users to purchase grocery and over-the-counter products through a single integrated portal
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.wexinc.com%2F&amp;esheet=54156003&amp;newsitemid=20241121379392&amp;lan=en-US&amp;anchor=WEX&amp;index=1&amp;md5=0f143c0913f61cdb39d9d67d39e31bdb">WEX</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEX#NYSE">WEX</a>), the global commerce platform that simplifies the business of running a business, today announced the release of the WEX Medicare Advantage marketplace, a new digital shopping solution embedded within the member experience of its Medicare Advantage supplemental benefits platform.
This expands the brick-and-mortar merchant network that Medicare Advantage members already have access to with an enhanced online shopping experience that allows members to purchase eligible over-the-counter (OTC) products and grocery items within WEX's integrated member portal. WEX's Medicare Advantage marketplace allows members to shop the way they choose – whether that's online or in a physical retail location.

WEX Announces The Release Of The WEX Medicare Advantage Marketplace, A New Digital Shopping Solution Embedded Within The Member Experience Of Its Medicare Advantage Supplemental Benefits Platform

Biotech

Events

General

PALI

Palisade Bio To Present PALI-2108 Data At 8th Annual Antifibrotic Drug Development Summit

Mizuho analyst Salim Syed maintains WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) with a Outperform and raises the price target from $19 to $22.

Price Target

Analyst Ratings

Mizuho Maintains Outperform on WAVE Life Sciences, Raises Price Target to $22

PYXS

Pyxis Oncology shares are trading lower after William Blair downgraded the stock from Outperform to Market Perform.

MACOM Technology Solns's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NYSE">MTSI</a>) short percent of float has fallen 4.1% since its last report. The company recently reported that it has 3.52 million shares sold short, which is 6.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>MACOM Technology Solns Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732194922_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MACOM Technology Solns has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MACOM Technology Solns's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, MACOM Technology Solns's peer group average for short interest as a percentage of float is 4.64%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

MTSI

Looking Into MACOM Technology Solns's Recent Short Interest

Workday's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NYSE">WDAY</a>) short percent of float has risen 7.21% since its last report. The company recently reported that it has 4.72 million shares sold short, which is 2.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.65 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Workday Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732194917_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Workday has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Workday's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Workday's peer group average for short interest as a percentage of float is 3.37%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

WDAY

Peering Into Workday's Recent Short Interest

O'Reilly Automotive's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NYSE">ORLY</a>) short percent of float has fallen 19.31% since its last report. The company recently reported that it has 935 thousand shares sold short, which is 1.63% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>O'Reilly Automotive Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732194912_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for O'Reilly Automotive has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing O'Reilly Automotive's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, O'Reilly Automotive's peer group average for short interest as a percentage of float is 11.82%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ORLY

How Is The Market Feeling About O'Reilly Automotive?

Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>), an advanced nuclear technology company, announced today that Atomic Alchemy Inc. (Atomic Alchemy), which Oklo has proposed to acquire through an all-stock transaction, has signed a Memorandum of Understanding (MOU) with Zeno Power Systems, Inc. (Zeno Power), a leading developer of commercial Radioisotope Power Systems (RPSs). Zeno Power's innovative power systems convert heat from radioisotopes into a reliable and consistent supply of clean energy for commercial and government customers in critical environments across space and terrestrial markets.
This MOU marks a key step in Atomic Alchemy's strategy to provide to the growing radioisotope market and expand its impact on critical missions, including space exploration and national defense. The MOU also represents an important milestone in furthering Atomic Alchemy's efforts to supply radioisotopes for non-medical applications and its goal to expand its presence in key markets such as defense and energy. Atomic Alchemy and Zeno Power expect to explore opportunities that build upon Atomic Alchemy's expertise in radioisotope production and recovery.
Through this collaboration, Atomic Alchemy expects to supply Zeno Power with strontium-90 (Sr-90), americium-241 (Am-241), and other radioisotopes needed to power RPSs like Radioisotope Thermoelectric Generators, or "nuclear batteries." These systems are designed for remote and off-grid environments, such as space and undersea applications. These radioisotopes can be produced as coproducts from Oklo's recycling processes.

OKLO

Atomic Alchemy, Oklo's Proposed Acquisition Target, Signs MOU With Zeno Power To Provide Fuel For Commercial Radioisotope Power Systems

Editor&#8217;s Note: The story has been updated to mention the quantity of restricted stock purchased by the CEO
On Thursday, Worksport Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) announced that it has retained Digital BD, Inc to monitor and investigate potentially illegal short-selling activity of its stock.
Rossi said the recent stock trading activity must reflect the business&#8217; health or significant growth pathways.
He said that the company sets new volume sales records almost daily while facing suspicious and volatile stock activity that it proposes to investigate thoroughly.
The company reported a 581% growth<a target="_blank" href="https://www.globenewswire.com/news-release/2024/11/13/2980701/0/en/Worksport-WKSP-Reports-Significant-581-YoY-Revenue-Growth-in-Q3-2024-Eyes-Record-2025.html" rel="noreferrer noopener">&nbsp;</a>in the third quarter and expects the 2025 revenue to exceed its market capitalization as of Wednesday. The sales are growing exponentially monthly, and three highly innovative products are set for near-term release, Rossi added.
Concurrently, CEO Steven Rossi has purchased 33,333 restricted Worksport shares at a 44% premium to the market price at $0.75 per share on November 19th.
Worksport has engaged&nbsp;Digital BD, a provider of&nbsp;Regulation SHO compliance monitoring, short sale trading analytics, and market integrity surveillance to safeguard shareholder value and address unusual trading patterns.
Digital BD will monitor daily short volume data from all U.S. exchanges, encompassing EXEMPT and&nbsp;NON-EXEMPT short sales, and will report its findings to the company.
Digital BD will scrutinize market makers trading&nbsp;Worksport shares daily for adherence to fair market-making requirements.
The Securities and Exchange Commission specifies that bona-fide market-making does not include activities related to speculative selling strategies for investment purposes that are disproportionate to usual market-making patterns.
Rossi expressed commitment to continuing its growth trajectory and protecting the interests of our shareholders.&nbsp;With the assistance of Digital BD, the company proposed to closely monitor trading activities to ensure compliance with all legal requirements.
CEO Rossi said Worksport as significantly undervalued and expects to unlock its true value. He also looks to discover, eliminate, and do everything possible to prevent future illegal short selling or open market manipulation of Worksport&#8217;s stock.
Worksport&#8217;s <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41953667/exclusive-worksports-q3-revenue-soars-581-as-new-product-lines-boost-growth-raises-2025-outlook" rel="noreferrer noopener">third-quarter revenue</a> reached $3.12 million, up by 581% year-over-year.
Price Action: WKSP stock traded higher by 5.42% to $0.53 premarket at the last check on Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42098028/qualcomms-shift-from-handsets-to-ai-and-automotive-wins-analysts-confidence" target="_blank" rel="noreferrer noopener">Qualcomm&#8217;s Shift From Handsets To AI And Automotive Wins Analysts&#8217; Confidence</a></li>
</ul>

Legal

Exclusives

WKSP

EXCLUSIVE: Worksport Ropes In Digital BD to Probe Short Selling, CEO Buys Stock At Premium (UPDATED)

Mizuho analyst Salim Syed maintains Nkarta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTX#NASDAQ">NKTX</a>) with a Outperform and lowers the price target from $20 to $16.

NKTX

Mizuho Maintains Outperform on Nkarta, Lowers Price Target to $16

SPAI

Safe Pro shares are trading higher after the company announced it entered into an MOU with a U.S. prime contractor for a purchase order for real-world landmine and unexploded ordnance imagery.

WORX

SCWorx shares are trading higher after the company announced it regained Nasdaq compliance requirements regarding its periodic reporting.

Intensity Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,237,113 shares of its common stock in a registered direct offering at a purchase price of $2.425 per share.
In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,237,113 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.95 per share, will be exercisable commencing six months from the date of issuance, and will expire five and one-half years following the date of issuance.
The gross proceeds from the Offerings, before deducting the placement agent's fees and other offering expenses payable by the Company, are expected to be approximately $3 million. The Company expects to use the net proceeds from the Offerings for general working capital.
A.G.P./Alliance Global Partners is acting as lead placement agent for the Offerings and Brookline Capital Markets, a division of Arcadia Securities, LLC, is acting as a co-placement agent for the Offerings. &nbsp;
The Offerings are expected to close on or about November 22, 2024, subject to the satisfaction of customary closing conditions.

Offerings

INTS

Intensity Therapeutics Announces Pricing Of $3M Registered Direct Offering With A Single Healthcare Focused Institutional Investor For The Issuance And Sale Of 1,237,113 Shares Of Its Common Stock In A Registered Direct Offering At A Purchase Price Of $2.425 Per Share And Concurrent Private Placement

Mizuho analyst Salim Syed maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Outperform and raises the price target from $90 to $100.

GILD

Mizuho Maintains Outperform on Gilead Sciences, Raises Price Target to $100

EVLV

Evolv Technology Reports Q3 Highlights: Over 2B Visitors Screened Since Inception, 465 New Multi-Year Subscriptions, Expansion To 1,100 School And 400 Hospital Buildings, Adds 3 Pro Sports Stadiums And 3 Fortune 500 Customers, With Daily Screening Of 3M Visitors And Tagging 500+ Firearms

MRUS

Merus shares are trading higher after Goldman Sachs initiated coverage on the stock with a Buy rating and announced a $73 price target.

Mizuho analyst Salim Syed maintains Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Outperform and raises the price target from $99 to $103.

CYTK

Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $103

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">49.8000</td>
<td align="right">0.260</td>
<td align="right">0.52</td>
<td>138.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">139.5500</td>
<td align="right">0.600</td>
<td align="right">0.43</td>
<td>1.7 million</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.3600</td>
<td align="right">0.140</td>
<td align="right">0.17</td>
<td>2.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">215.0000</td>
<td align="right">0.380</td>
<td align="right">0.17</td>
<td>280</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">143.0900</td>
<td align="right">0.210</td>
<td align="right">0.14</td>
<td>8.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">231.3500</td>
<td align="right">0.220</td>
<td align="right">0.09</td>
<td>27.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.5000</td>
<td align="right">0.030</td>
<td align="right">0.06</td>
<td>451</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.5392</td>
<td align="right">0.049</td>
<td align="right">0.06</td>
<td>3.9K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">96.22</td>
<td align="right">-0.12</td>
<td align="right">-0.13</td>
<td>27.6K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For November 21, 2024

Fixed-Income Outlook: Strategies For A Controlled Descent